MANGALAMNSEMangalam Drugs And Organics Limited· PharmaceuticalsMinimalNeutral
Announced Fri, 4 Jul · 24:33 IST

Govardhan M. Dhoot has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Govardhan M. Dhoot, a promoter of Mangalam Drugs and Organics Limited, has submitted an annual declaration to BSE and NSE under Regulation 31(4) of the SEBI Takeover Regulations, 2011. The declaration is filed on behalf of all promoters, members of the promoter group, and persons acting in concert. In the filing, the promoter confirms that no new encumbrance (such as pledge, lien, or charge) has been created on the company's shares, directly or indirectly, beyond what was already disclosed during financial year 2024-25. This is a routine yearly compliance requirement for promoters of listed companies. No transactions or shareholding changes are involved in this filing.

Likely market impact

This is a routine regulatory compliance disclosure and is neutral for shareholders. It simply confirms that promoters have not secretly pledged or encumbered their shares beyond what is already on record, which provides some comfort on shareholding transparency.